Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity

ClinicalTrials.gov ID: NCT07311850

Public ClinicalTrials.gov record NCT07311850. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 9, 2026, 12:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluating The Efficacy and Safety of MET097, a Fully-Biased, Ultra Long-Acting GLP-1RA, In People With Overweight or Obesity: A Phase 3, Multi-Center Randomized, Controlled Trial (VESPER-4)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study investigates the efficacy and safety of once weekly injectable MET097 in adult participants with obesity or overweight with weight-related comorbidities excluding T2D. This trial will last for a duration of 84 weeks. The primary endpoint will be assessed after 64 weeks of treatment with the secondary at 84 weeks.

Study identification

NCT ID
NCT07311850
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
3,578 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 18, 2025
Primary completion
Sep 20, 2027
Completion
Apr 24, 2028
Last update posted
Sep 3, 2026

2025 – 2028

United States locations

U.S. sites
37
U.S. states
15
U.S. cities
36
Facility City State ZIP Site status
Headlands Research Scottsdale Arizona 85260
Alliance Research Institute Canoga Park California 91304
Rolling Oaks Radiology -Palms Oxnard California 93036
Clinical Innovations, Inc dba CITrials Riverside California 92506
Peninsula Headlands LLC Rolling Hills California 90274
Collaborative Neuroscience Research, LLC Torrance California 90504
CenExcel Rocky Mountain Clinical Research, LLC Englewood Colorado 80113
Research Centers of America Hollywood Florida 33024
Future Medical Research (Civia Health) Longwood Florida 32750
Advanced Clinical Research Miami Florida 33156
Oviedo Medical Research Oviedo Florida 32765
CenExel FCR - ForCare Clinical Research Tampa Florida 33613
DelRicht Research Atlanta Georgia 30329
CenExel iResearch, LLC Savannah Georgia 31405
CenExel CBH Health Gaithersburg Maryland 20877
Clinical Research Professionals Chesterfield Missouri 63005
Upgrade Performance Institute Elkhorn Nebraska 68022
Quality Clinical Research Inc Omaha Nebraska 68114
Primary clinical Research Papillion Nebraska 68046
Hassman Research Institute Marlton New Jersey 08053
Forum Health_Cary (Civia) Cary North Carolina 27511
Eximia EquiHealth Research Durham North Carolina 27704
Sahana Optometry PLLC dba Family Eye Wellness Holly Springs North Carolina 27540
TMA Headlands LLC - Wilmington Wilmington North Carolina 28403
TMA Headlands LLC Wilmington North Carolina 28403
Summit Headlands LLC Portland Oregon 97210
Tribe Clinical Research LLC.- Greenville Greenville South Carolina 29607
Palmetto Internal Medicine Mauldin South Carolina 29662
Tribe Clinical Research LLC. - Spartanburg Spartanburg South Carolina 29301
Civia Health Goodlettsville Goodlettsville Tennessee 37072
Civia Health Nashville La Vergne Tennessee 37086
Civia Health Memphis Memphis Tennessee 38117
Forum Austin (Civia Health) Austin Texas 78758
Cedar Health Research Dallas Texas 75251
GLRI El Paso Research El Paso Texas 79936
Dallas Clinical Research Center (Pillar Clinical Research) Richardson Texas 75080
Pantheon Clinical Research Bountiful Utah 84010

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 132 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07311850, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 3, 2026 · Synced Sep 9, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07311850 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →